IN TREATMENT Needs To Go In For… You Know

In Treatment is good, but it can’t be a good sign when the network is blaming its poor ratings for screwing up the whole schedule:

HBO said one of the key reasons it had a substandard month was that the low-rated nightly “In Treatment” half-hour series has thrown off the network’s normal primetime schedule, forcing it to shift movies and other programming to one of its multiplex networks.

The damage done to HBO by the failure of “In Treatment” to catch on comes through in the year-to-year comparisons, which show HBO off in primetime by 36% in total viewers, and down by 40% in 18-49, compared to the numbers in February 2007.

The total-day falloffs are just as nerve-wracking: HBO is down by 36% in total viewers February to February and by 34% in A18-49.

On the bright side, the same article says that John Adams is doing well; other cable networks are surpassing HBO on series, but most of them don’t have the resources or schedule flexibility to compete with them on miniseries.

Looking for more?

Get the Best of Maclean's sent straight to your inbox. Sign up for news, commentary and analysis.